Abaloparatide for the treatment of postmenopausal osteoporosis.
Luca Pietrogrande, Estelle R. Raimondo
págs. 293-304
Ibrutinib for the treatment of patients with chronic graft-versus-host disease after failure of one or more lines of systemic therapy.
L.T Rahmat, Aaron C. Logan
págs. 305-314
Plasmid DNA vaccines: where are we now?
F. Ghaffarifar
págs. 315-334
Annual Drug Information Association (DIA) Europe 2018 (April 17-19, 2018 – Basel, Switzerland).
S Hamaui Cuadrado, Marta Guinart Vidal
págs. 335-342
New product intros (burosumab-twza, erenumab-aooe [first-in-class], evocalcet, ibalizumab-uiyk [first-in-class], netarsudil mesylate)
págs. 343-344
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: